PTGS2 and chronic myelogenous leukemia, BCR-ABL1 positive: To compose the evidence framework regarding the possible relationship between the expression of PTGS1 and PTGS2 genes and CML disease status, an in vitro study was performed using the K562 cell model to evaluate the expression of both genes according to the time of exposure to TKI (Imatinib mesylate).